Updated Jul 16, 2026
Ives Jeffrey L. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Based on the June 5, 2026 SEC filing, Ives Jeffrey L. serves as a director on the board of Acumen Pharmaceuticals, Inc. Publicly available biographical information beyond this board role is not evident from the provided SEC context, and no additional details about his education, career history, or other affiliations are disclosed here.
| Role | Director |
|---|---|
| Notability | 15/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-05 | ABOS | Acumen Pharmaceuticals, Inc. | A — Grant or award | 35.5K | $0.00 |
Based on the June 5, 2026 SEC filing, Ives Jeffrey L. serves as a director on the board of Acumen Pharmaceuticals, Inc. Publicly available biographical information beyond this board role is not evident from the provided SEC context, and no additional details about his education, career history, or other affiliations are disclosed here.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ives Jeffrey L. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.